Cargando…
P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF) VS POMALIDOMIDE/LOW DOSE DEXAMETHASONE (PD) IN THE DREAMM-3 STUDY
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431560/ http://dx.doi.org/10.1097/01.HS9.0000970760.35249.ae |
_version_ | 1785091230063919104 |
---|---|
author | Hungria, Vania Weisel, Katja Currie, Brooke Perera, Sue Sule, Neal He, Wei Mckeown, Astrid Sapra, Sandhya Nelsen, Linda LI, Mary Barale, Sophie Boyle, Julia Mcpoyle, Kaytlyn Dimopoulos, Meletios A. |
author_facet | Hungria, Vania Weisel, Katja Currie, Brooke Perera, Sue Sule, Neal He, Wei Mckeown, Astrid Sapra, Sandhya Nelsen, Linda LI, Mary Barale, Sophie Boyle, Julia Mcpoyle, Kaytlyn Dimopoulos, Meletios A. |
author_sort | Hungria, Vania |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10431560 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104315602023-08-17 P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF) VS POMALIDOMIDE/LOW DOSE DEXAMETHASONE (PD) IN THE DREAMM-3 STUDY Hungria, Vania Weisel, Katja Currie, Brooke Perera, Sue Sule, Neal He, Wei Mckeown, Astrid Sapra, Sandhya Nelsen, Linda LI, Mary Barale, Sophie Boyle, Julia Mcpoyle, Kaytlyn Dimopoulos, Meletios A. Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431560/ http://dx.doi.org/10.1097/01.HS9.0000970760.35249.ae Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Posters Hungria, Vania Weisel, Katja Currie, Brooke Perera, Sue Sule, Neal He, Wei Mckeown, Astrid Sapra, Sandhya Nelsen, Linda LI, Mary Barale, Sophie Boyle, Julia Mcpoyle, Kaytlyn Dimopoulos, Meletios A. P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF) VS POMALIDOMIDE/LOW DOSE DEXAMETHASONE (PD) IN THE DREAMM-3 STUDY |
title | P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF) VS POMALIDOMIDE/LOW DOSE DEXAMETHASONE (PD) IN THE DREAMM-3 STUDY |
title_full | P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF) VS POMALIDOMIDE/LOW DOSE DEXAMETHASONE (PD) IN THE DREAMM-3 STUDY |
title_fullStr | P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF) VS POMALIDOMIDE/LOW DOSE DEXAMETHASONE (PD) IN THE DREAMM-3 STUDY |
title_full_unstemmed | P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF) VS POMALIDOMIDE/LOW DOSE DEXAMETHASONE (PD) IN THE DREAMM-3 STUDY |
title_short | P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF) VS POMALIDOMIDE/LOW DOSE DEXAMETHASONE (PD) IN THE DREAMM-3 STUDY |
title_sort | p964: patient (pt)-reported outcomes in pts with relapsed/refractory multiple myeloma (rrmm) treated with belantamab mafodotin (belamaf) vs pomalidomide/low dose dexamethasone (pd) in the dreamm-3 study |
topic | Posters |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431560/ http://dx.doi.org/10.1097/01.HS9.0000970760.35249.ae |
work_keys_str_mv | AT hungriavania p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study AT weiselkatja p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study AT curriebrooke p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study AT pererasue p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study AT suleneal p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study AT hewei p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study AT mckeownastrid p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study AT saprasandhya p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study AT nelsenlinda p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study AT limary p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study AT baralesophie p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study AT boylejulia p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study AT mcpoylekaytlyn p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study AT dimopoulosmeletiosa p964patientptreportedoutcomesinptswithrelapsedrefractorymultiplemyelomarrmmtreatedwithbelantamabmafodotinbelamafvspomalidomidelowdosedexamethasonepdinthedreamm3study |